Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-25-047089
Filing Date
2025-05-12
Accepted
2025-05-12 09:25:24
Documents
1
Period of Report
2025-05-06

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2514779-1_4aseq1.html 4/A  
1 OWNERSHIP DOCUMENT tm2514779-1_4aseq1.xml 4/A 12464
  Complete submission text file 0001104659-25-047089.txt   13876
Mailing Address 27 RIPPLEVALE GROVE LONDON X0 N1 1HS
Business Address
Mosseri Marlio Charles (Reporting) CIK: 0001806384 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-41264 | Film No.: 25932906

Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Issuer) CIK: 0001875558 (see all company filings)

EIN.: 862405608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)